Leda Health Wins CES 2022 Innovation Award for Early Evidence Kit and Platform

NEXT STORY
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Initiated Phase 1/1b Clinical Trial of ITK Inhibitor CPI-818 in China
PREV STORY
Molecular Partners Reports Disclosure of Major Shareholder as per Swiss Stock Exchange Regulations
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Radius Health Submits New Drug Application to the U.S. Food and Drug Administration for Abaloparatide-SC for the Treatment of Postmenopausal Women with Osteoporosis

– Significant Reduction in the Risk of Vertebral, Nonvertebral, Clinical and Major Osteoporotic Fractures ...

author_avatar
NASDAQ Market News

GENFIT: Contributing Significantly to the European LITMUS Initiative on NASH Biomarkers

GENFIT: Contributing Significantly to the European LITMUS Initiative on NASH Biomarkers GENFIT significantly contributes ...

author_avatar
NASDAQ Market News

Aduro Biotech Announces Appointment of Leading Immunotherapy and Oncology Experts to Scientific Advisory Board

BERKELEY, Calif., Jan. 26, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical ...

author_avatar
NASDAQ Market News